About: Immix Biopharma, Inc., a clinical-stage biopharmaceutical company, engages in the development of chimeric antigen receptor cell therapy in light chain Amyloidosis and immune-mediated diseases in the United States and Australia. The company' lead product is NXC-201 for relapsed/refractory AL Amyloidos. Immix Biopharma, Inc., was incorporated in 2012 and is headquartered in Los Angeles, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $7.98 (-1.78%)
IMMX NASDAQ Immix Biopharma Inc
Carregando status da lista de acompanhamento…
Immix Biopharma Inc share price
Atividade de preço de IMMX
Último preço
$ 7,980
Variação (24h)
-0,01 USD (0,13%)
Volume
1.07M
Volume (média 4 sem.)
-
Abertura
$ 8,11
Variação do dia
$ 7,84 - $ 8,36
Fechamento anterior
$ 7,99
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
IMMX price performance
-2,09%
5D
-24,29%
1M
+52,58%
YTD
+114,52%
1Y
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals